Compare AIN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIN | PLSE |
|---|---|---|
| Founded | 1895 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 1994 | 2015 |
| Metric | AIN | PLSE |
|---|---|---|
| Price | $57.80 | $20.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $60.25 | $22.00 |
| AVG Volume (30 Days) | 211.6K | ★ 465.1K |
| Earning Date | 06-01-2026 | 06-01-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,054,132,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,250.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.29 | N/A |
| 52 Week Low | $41.15 | $12.56 |
| 52 Week High | $80.71 | $26.30 |
| Indicator | AIN | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 52.48 |
| Support Level | $51.37 | $14.49 |
| Resistance Level | $53.88 | $26.30 |
| Average True Range (ATR) | 2.08 | 2.43 |
| MACD | -0.41 | -0.18 |
| Stochastic Oscillator | 2.41 | 51.12 |
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.